Metraipolis › archive › dc_0ca1dfa3122f

Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK-PD modelling to optimize temozolomide timing — Europe PMC PMID:41387951

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41387951
DOI
10.1038/s41698-[numero omesso]-z
License (as archived)
solo-consultazione
Archived
2026-11-07T16:37:22.614Z
SHA-256 of the archived text
ce1277257b4fd89aca74530d3e0782e8d6da856e2f03553562136c992d6b4cda
Stable URL of this page
https://metraipolis.com/documento/dc_0ca1dfa3122f

How to cite

Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK-PD modelling to optimize temozolomide timing — Europe PMC PMID:41387951 — Europe PMC (en), https://europepmc.org/article/MED/41387951 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0ca1dfa3122f (Metraipolis archive dc_0ca1dfa3122f, sha256 ce1277257b4fd89aca74530d3e0782e8d6da856e2f03553562136c992d6b4cda)
BibTeX
@misc{dc0ca1dfa3122f,
  title = {Personalized chronotherapy in glioblastoma: integrating circadian profiling and PK-PD modelling to optimize temozolomide timing — Europe PMC PMID:41387951},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41387951},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0ca1dfa3122f; sha256 ce1277257b4fd89aca74530d3e0782e8d6da856e2f03553562136c992d6b4cda},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41387951. Agents can read the archived copy with the MCP tool read_document.